Looking into severe dengue : determinants of severe dengue in French overseas territories | Pandemic PACT Tracker

Key facts

Disease
Other
Start & end year
2023
Known Financial Commitments (USD)
$2,060,034.73
Funder
Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)
Principal Investigator
CABIÉ André
Research Location
France
Lead Research Institution
CHU de Martinique (CIC1424)
Research Priority Alignment
N/A

Research Category
Epidemiological studies
Research Subcategory
Disease susceptibility
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

N/A

3 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitis.

Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis.

Authors
Gervais A, Bastard P, Zhang Q, Jaffar-Bandjee MC, Bizien L, Dahmane L, Moiton MP, Jabot J, Cally R, Maillard A, Frumence E, de Lamballerie X, Yazdanpanah Y, Rosain J, Cobat A, Abel L, Puel A, Ferdynus C, Mosnier É, Gérardin P, Zhang SY, Casanova JL.
Publish Year
2026
Journal
Proceedings of the National Academy of Sciences of the United States of America
DOI
10.1073/pnas.2532212123

View at Europe PMC

Auto-Abs against type I IFNs: Strong, common, and global determinants of severe arboviral diseases.